Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. more
Time Frame | PRPO | Sector | S&P500 |
---|---|---|---|
1-Week Return | 10.53% | 0.49% | -0.42% |
1-Month Return | 3.85% | -3.1% | -2.2% |
3-Month Return | -7.34% | -8.59% | 2.38% |
6-Month Return | 27.53% | -4.57% | 5.1% |
1-Year Return | 3.45% | -0.94% | 23.79% |
3-Year Return | -80.08% | 2.88% | 26.66% |
5-Year Return | -84.03% | 35.84% | 81.16% |
10-Year Return | -99.96% | 98.8% | 191.72% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 3.13M | 6.09M | 8.85M | 9.41M | 15.20M | [{"date":"2019-12-31","value":20.58,"profit":true},{"date":"2020-12-31","value":40.09,"profit":true},{"date":"2021-12-31","value":58.23,"profit":true},{"date":"2022-12-31","value":61.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 2.91M | 4.94M | 6.46M | 6.90M | 9.18M | [{"date":"2019-12-31","value":31.68,"profit":true},{"date":"2020-12-31","value":53.84,"profit":true},{"date":"2021-12-31","value":70.35,"profit":true},{"date":"2022-12-31","value":75.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 219.00K | 1.15M | 2.39M | 2.51M | 6.02M | [{"date":"2019-12-31","value":3.64,"profit":true},{"date":"2020-12-31","value":19.11,"profit":true},{"date":"2021-12-31","value":39.75,"profit":true},{"date":"2022-12-31","value":41.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 7.00% | 18.88% | 27.03% | 26.67% | 39.60% | [{"date":"2019-12-31","value":17.69,"profit":true},{"date":"2020-12-31","value":47.67,"profit":true},{"date":"2021-12-31","value":68.26,"profit":true},{"date":"2022-12-31","value":67.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 9.62M | 10.30M | 12.01M | 15.31M | 13.64M | [{"date":"2019-12-31","value":62.87,"profit":true},{"date":"2020-12-31","value":67.26,"profit":true},{"date":"2021-12-31","value":78.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.1,"profit":true}] |
Operating Income | (9.40M) | (9.15M) | (9.61M) | (12.80M) | (7.62M) | [{"date":"2019-12-31","value":-940400000,"profit":false},{"date":"2020-12-31","value":-914600000,"profit":false},{"date":"2021-12-31","value":-961300000,"profit":false},{"date":"2022-12-31","value":-1279700000,"profit":false},{"date":"2023-12-31","value":-762000000,"profit":false}] |
Total Non-Operating Income/Expense | (4.38M) | (1.92M) | 1.08M | 607.00K | 1.75M | [{"date":"2019-12-31","value":-250.54,"profit":false},{"date":"2020-12-31","value":-109.89,"profit":false},{"date":"2021-12-31","value":61.52,"profit":true},{"date":"2022-12-31","value":34.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (13.31M) | (10.60M) | (8.52M) | (12.18M) | (5.85M) | [{"date":"2019-12-31","value":-1331300000,"profit":false},{"date":"2020-12-31","value":-1059800000,"profit":false},{"date":"2021-12-31","value":-851700000,"profit":false},{"date":"2022-12-31","value":-1217800000,"profit":false},{"date":"2023-12-31","value":-585300000,"profit":false}] |
Income Taxes | (70.00K) | 1.63M | 33.00K | 25.00K | 1.35M | [{"date":"2019-12-31","value":-4.29,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":2.02,"profit":true},{"date":"2022-12-31","value":1.53,"profit":true},{"date":"2023-12-31","value":82.67,"profit":true}] |
Income After Taxes | (13.24M) | (12.23M) | (8.55M) | (12.20M) | (7.20M) | [{"date":"2019-12-31","value":-1324300000,"profit":false},{"date":"2020-12-31","value":-1223000000,"profit":false},{"date":"2021-12-31","value":-855000000,"profit":false},{"date":"2022-12-31","value":-1220300000,"profit":false},{"date":"2023-12-31","value":-720210500,"profit":false}] |
Income From Continuous Operations | (13.24M) | (10.60M) | (8.52M) | (12.18M) | (9.06M) | [{"date":"2019-12-31","value":-1324300000,"profit":false},{"date":"2020-12-31","value":-1059800000,"profit":false},{"date":"2021-12-31","value":-851700000,"profit":false},{"date":"2022-12-31","value":-1217800000,"profit":false},{"date":"2023-12-31","value":-906100000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (13.24M) | (12.23M) | (8.55M) | (12.20M) | (5.85M) | [{"date":"2019-12-31","value":-1324300000,"profit":false},{"date":"2020-12-31","value":-1223000000,"profit":false},{"date":"2021-12-31","value":-855000000,"profit":false},{"date":"2022-12-31","value":-1220300000,"profit":false},{"date":"2023-12-31","value":-585300000,"profit":false}] |
EPS (Diluted) | (1.74) | (0.90) | (0.39) | (0.40) | - | [{"date":"2019-12-31","value":-174,"profit":false},{"date":"2020-12-31","value":-90,"profit":false},{"date":"2021-12-31","value":-39,"profit":false},{"date":"2022-12-31","value":-40,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
PRPO | |
---|---|
Cash Ratio | 0.24 |
Current Ratio | 0.73 |
Quick Ratio | 0.60 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PRPO | |
---|---|
ROA (LTM) | -18.98% |
ROE (LTM) | -29.22% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PRPO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.30 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.70 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PRPO | |
---|---|
Trailing PE | NM |
Forward PE | 15.43 |
P/S (TTM) | 0.54 |
P/B | 0.76 |
Price/FCF | NM |
EV/R | 0.54 |
EV/Ebitda | NM |
PEG | NM |
Precipio Inc (PRPO) share price today is $6.1344
Yes, Indians can buy shares of Precipio Inc (PRPO) on Vested. To buy Precipio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PRPO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Precipio Inc (PRPO) via the Vested app. You can start investing in Precipio Inc (PRPO) with a minimum investment of $1.
You can invest in shares of Precipio Inc (PRPO) via Vested in three simple steps:
The 52-week high price of Precipio Inc (PRPO) is $7.3. The 52-week low price of Precipio Inc (PRPO) is $4.31.
The price-to-earnings (P/E) ratio of Precipio Inc (PRPO) is
The price-to-book (P/B) ratio of Precipio Inc (PRPO) is 0.76
The dividend yield of Precipio Inc (PRPO) is 0.00%
The market capitalization of Precipio Inc (PRPO) is $9.09M
The stock symbol (or ticker) of Precipio Inc is PRPO